IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
IMPL
Delisted
IMPL was delisted on the 15th of December, 2023.
39 hedge funds and large institutions have $73.9M invested in Impel Pharmaceuticals Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 1 closing their positions.
Holders
39
Holders Change
+3
Holders Change %
+8.33%
% of All Funds
0.67%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
4
Increased
11
Reduced
10
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
Millennium Management
New York
|
$155K |
2 |
BCM
2
Bridgeway Capital Management
Houston,
Texas
|
$333K |
3 |
3
Morgan Stanley
New York
|
$55K |
4 |
E
4
Ergoteles
New York
|
$119K |
5 |
5
Goldman Sachs
New York
|
$55K |